Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TCRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTScan Therapeutics reports Q1 2026 financial results
Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read
Key Changes
-
medium
TScan announced first quarter 2026 financial results via press release on May 6, 2026. The 8-K filing itself contains no financial figures—only references the attached press release.
Item 2.02 verify on EDGAR → -
low
This is a routine earnings disclosure filing. The press release (Exhibit 99.1) contains the actual financial data and operational updates.
8-K: Exhibit 99.1 view on EDGAR →
Summary
TScan Therapeutics filed an 8-K on May 6, 2026, to announce its first quarter 2026 financial results. This is a standard quarterly earnings disclosure—the filing itself is procedural and contains no financial details. The actual results, commentary, and operational updates are in the attached press release (Exhibit 99.1), which investors should review for specifics on cash position, clinical trial progress, and management outlook.
For retail holders, this filing signals routine quarterly reporting. The key takeaway is to review the press release for any updates on TScan's clinical programs, cash runway, and enrollment milestones. Watch for any guidance changes or trial timeline updates in the full release, as those would be the material drivers for the stock.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
TScan Therapeutics filed an 8-K referencing a press release dated May 6, 2026, with no material business details disclosed in the filing itself.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed:
Exhibit No. | Description | 99.1
Press Release issued by TScan Therapeutics, Inc., dated May 6, 2026.
The 8-K references Item 2.02, which typically covers results of operations and financial condition. A press release dated May 6, 2026 is attached as Exhibit 99.1, but the filing body provides no details about the content of that release. The actual material disclosure would be in the press release itself, not in this procedural 8-K shell.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify